Actin disruption agents induce phosphorylation of histone H2AX in human breast adenocarcinoma MCF-7 cells
Related Experiment Video
Updated: Jun 3, 2026

Quantification of γH2AX Foci in Response to Ionising Radiation
Published on: April 6, 2010
Ik Jae Shin1, Yong-Tae Ahn, Yongkuk Kim
1Joint Research Center of Pusan National University-Fraunhofer IGB, Busan 609-735, Republic of Korea.
Abstract:
Modified actin dynamics are a unique feature of transformed cancer cells and thereby promising targets for cancer chemotherapy. While latrunculin B (LB) and pectenotoxin-2 (PTX-2), both derived from natural sources, inhibit actin polymerization, jasplakinolide (JSP) prevents actin depolymerization. The purpose of this study was to examine the detailed molecular action of actin disruption inducing apoptosis via double strand breaks (DSBs). Actin disruption induced phosphorylation of H2AX, a well known DSB marker leading to G2 arrest and consequently resulted in apoptosis on MCF-7 cancer cells. Cells impaired by actin disruption activated Erk (extracellular signal-related kinase) and p53 protein was involved in DNA damage responses, but did not change the levels of p21Cip1/WAF1 protein in MCF-7 cells. To overcome the DSBs by actin disruption, MCF-7 cells set the repair system through the homologous recombination (HR) pathway. These results indicate that actin is involved in the signaling inducing DSBs and HR repair as well as G2 cell cycle arrest in human cancer. Therefore, the results suggest that actin disruption might be a potential candidate for developing anti-cancer therapies in human breast cancer.
Insights
Targeting modified actin dynamics in cancer cells shows promise for chemotherapy. Actin disruption induces DNA damage, cell cycle arrest, and apoptosis in breast cancer cells, suggesting a potential therapeutic strategy.
Area of Science:
- Cell Biology
- Molecular Oncology
- Biochemistry
Background:
- Modified actin dynamics are characteristic of cancer cells, presenting potential therapeutic targets.
- Actin-disrupting agents like latrunculin B and jasplakinolide offer avenues for cancer treatment.
- Understanding the precise molecular mechanisms of actin disruption in cancer is crucial.
Purpose of the Study:
- To investigate the molecular actions of actin disruption in inducing apoptosis via double-strand breaks (DSBs).
- To analyze the cellular responses, including DNA damage signaling and cell cycle arrest, following actin disruption in cancer cells.
Main Methods:
- Utilized MCF-7 cancer cells to study the effects of actin disruption.
- Assessed DNA damage markers (e.g., phosphorylated H2AX), cell cycle progression (G2 arrest), and apoptosis.
- Investigated the activation of signaling pathways like Erk and the involvement of p53 and p21Cip1/WAF1.
- Examined the DNA repair mechanisms, specifically homologous recombination (HR), in response to actin disruption.
Main Results:
- Actin disruption triggered phosphorylation of H2AX, indicating DSBs, and led to G2 cell cycle arrest and apoptosis in MCF-7 cells.
- Activation of Erk and involvement of p53 were observed in response to DNA damage, without altering p21Cip1/WAF1 levels.
- MCF-7 cells initiated DNA repair via the homologous recombination pathway to counteract DSBs induced by actin disruption.
Conclusions:
- Actin plays a significant role in signaling pathways that induce DSBs, homologous recombination repair, and G2 cell cycle arrest in human cancers.
- Actin disruption emerges as a potential therapeutic strategy for human breast cancer treatment.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Anaphase Promoting Complex
Actin Filament Depolymerization
In F-actin, the ADF/cofilin proteins...
Generation of Straight or Branched Actin Filaments
Arp2/3 Complex
Arp2/3 complex is a seven-subunit complex consisting of two proteins similar to actin- Arp2 and Arp3, and five other subunits that help keep Arp2 and Arp3 inactive. When required, the complex is...
PI3K/mTOR/AKT Signaling Pathway

